Jun 21, 2021

Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference Call on June 24, 2021

Jun 10, 2021

Aethlon Medical Announces $12.425 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jun 3, 2021

Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemopurifier®

Mar 1, 2021

Aethlon Medical to Participate in Two Upcoming Healthcare Investor Conferences

Feb 10, 2021

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

Feb 4, 2021

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 10, 2021

Jan 6, 2021

Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer

Jan 4, 2021

Aethlon Medical to Present at the H.C. Wainwright BioConnect 2021 Conference

Dec 16, 2020

Aethlon Medical Announces First Patient Treated in First-in-Human Clinical Trial of HEMOPURIFIER® in Head and Neck Cancer

Nov 3, 2020

Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer